Back

Valvular heart disease in Cancer patiEntS - prevAlence, Relevance, and therapeutic management - The CESAR study

20 June 2026 (14:30 - 15:15)
Organised by: Logo
Congress Presentation Part of: Structural cardiac complications in cancer: evidence, procedures and guideline implementation Diagnosis and Management of Cardiovascular Disease in Patients with Cancer Delegates Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Doctor Laurenz Hauptmann

Medical University of Vienna, Vienna (Austria)

4 More presentations in this session

Presentation thumbnail
Etiology and long-term outcomes of patients undergoing pericardiocentesis for malignant cardiac tamponade
Doctor A. Stapor (Krakow, PL)
Abstract Slides
Presentation thumbnail
Intrapericardial corticosteroid therapy in cancer patients requiring repeated pericardiocentesis
Associate Professor N. Lee (Hwasun-Gun, KR)
Abstract Slides
Presentation thumbnail
Outcomes of patients with cancer undergoing left atrial appendage closure: a systematic review and meta-analysis
Doctor L. Amore (Rome, IT)
Abstract Slides
Presentation thumbnail
Representation, characterisation and reporting of amyloidosis and cardiovascular disease in phase III multiple myeloma trials
Doctor O. Henriques Peck (Glasgow, GB)
Abstract Slides

Access the full session

Session thumbnail
Structural cardiac complications in cancer: evidence, procedures and guideline implementation

The Event

Event poster

ESC Cardio-Oncology 2026

20 June 2026 14:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources